Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 80, 153381
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 27 references indexed in Scilit:
- LncRNA PVT1 links Myc to glycolytic metabolism upon CD4+ T cell activation and Sjögren's syndrome-like autoimmune responseJournal of Autoimmunity, 2020
- Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2–STAT3 signaling pathwayPhytomedicine, 2019
- TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-κB mediated signaling in B-cellsHaematologica, 2018
- Systemic ST6Gal-1 Is a Pro-survival Factor for Murine Transitional B CellsFrontiers in Immunology, 2018
- Canonical NF-κB signaling is uniquely required for the long-term persistence of functional mature B cellsProceedings of the National Academy of Sciences, 2016
- Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activationProceedings of the National Academy of Sciences, 2015
- A Pathway Switch Directs BAFF Signaling to Distinct NFκB Transcription Factors in Maturing and Proliferating B CellsCell Reports, 2014
- B cells in Sjögren's syndrome: From pathophysiology to diagnosis and treatmentJournal of Autoimmunity, 2012
- Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic miceJournal of Autoimmunity, 2011
- Artesunate: The Best Drug in the Treatment of Severe and Complicated MalariaPharmaceuticals, 2010